Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.
The purpose of this study is to compare the effectiveness of oxybutynin, functional electrostimulation (FES), and pelvic floor training (PFT) for treatment of women with detrusor overactivity. Sixty-four subjects were randomized to oxybutynin (n=22), FES (n=21), or PFT (n=21). Women were evaluated before and after completion of 12 weeks of treatment by subjective response, voiding diary, and urodynamic test. There was subjective symptomatic improvement in 77% of the women treated with oxybutynin, 52% with FES, and 76% with PFT. Urgency resolved in 64% of women treated with oxybutynin, 52% with FES, and in 57% with PFT. Urodynamic evaluation was normal in 36% treated with oxybutynin, 57% with FES, and 52% with PFT. Maximum detrusor involuntary contraction pressure decreased in all groups (p<0.05). All treatments were equally effective. Subjective reduction of urge-incontinence episodes was associated with symptomatic improvement.
Arruda
Raquel M
RM
Department of Urogynecology, Federal University of São Paulo, R. Loefgreen, 1654/14, Vila. Clementino, 04040-002 São Paulo, Brazil. raquel.arruda@yahoo.com.br
Castro
Rodrigo A
RA
Sousa
Gabriela C
GC
Sartori
Marair G F
MG
Baracat
Edmund C
EC
Girão
Manoel J B C
MJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004599:Electric Stimulation Therapy; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use*; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D017773:Pelvic Floor; D026741:Physical Therapy Modalities; D011446:Prospective Studies; D053201:Urinary Bladder, Overactive / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D014563:Urodynamics
D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin